FDA Advisory No. 2017-305
Public Health Warning Against the Use of Counterfeit Cosmetic Products (Batch 10)
The Food and Drug Administration (FDA) hereby advises the public against the purchase and use of NIVEA EXTRA WHITE FIRMING BODY LOTION 50X VITAMIN C Q10 & CAMU CAMU 400ML with Batch/ Lot number SKK-L18 and Manufacturing/ Expiry date 2017/05 / 2020/05 whose pictures appears below:
FDA, in coordination with the Market Authorization Holder (MAH), Beiersdorf Philippines Incorporated, has verified that Nivea Extra White Firming Body Lotion 50x Vitamin C Q10 & Camu Camu 400mL products with this particular batch/lot number and manufacturing/expiry date are COUNTERFEIT.
According to the MAH, the batch coding seen in Figure 3 is different from their standard full numerical batch codes and the standard bottles have manufacturing dates only, printed in format of month/year. The plastic covering seen in Figures 1 and 2 are different from the authentic Nivea Extra White Firming Body Lotion 50x Vitamin C Q10 & Camu Camu 400mL which have a crisp, tight plastic covering from the neck of the bottle up to the pump.
Counterfeit products, not having gone through the required safety assessment and the verification process of the FDA, pose potential health hazards to the consuming public since their safety and purity cannot be guaranteed. The dangers/hazards may come from ingredients that are not allowed to be part of a cosmetic product or from the contamination of heavy metals such as lead and mercury. The use of substandard and possibly adulterated cosmetic products may result to adverse reactions including but not limited to skin irritation, itchiness, anaphylactic shock and organ failure.
In light of the above, the public is advised to be vigilant against buying and using the aforementioned counterfeit cosmetic product. Moreover, the public is also advised to be vigilant against cosmetic products that might not be duly notified with FDA. Always check if a cosmetic product has been notified with FDA before purchasing it by making use of the embedded Search feature of the FDA website accessible at www.fda.gov.ph.
All concerned establishments are warned not to distribute the above-identified violative cosmetic product, otherwise, regulatory actions and sanctions shall be strictly pursued.
All Local Government Units (LGUs) and Law Enforcement Agencies (LEAs) are requested to ensure that the product is not sold or made available in their localities or areas of jurisdiction.
Dissemination of the information to all concerned is requested